HEADER ISOMERASE 09-MAR-20 6M4V TITLE CRYSTAL STRUCTURE OF MBP FUSED SPLIT FKBP IN COMPLEX WITH RAPAMYCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHIMERA OF MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN COMPND 3 AND PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A; COMPND 4 CHAIN: A, C; COMPND 5 SYNONYM: MMBP,MALTODEXTRIN-BINDING PROTEIN,MALTOSE-BINDING PROTEIN, COMPND 6 MBP,PPIASE FKBP1A,12 KDA FK506-BINDING PROTEIN,FKBP-12,CALSTABIN-1, COMPND 7 FK506-BINDING PROTEIN 1A,FKBP-1A,IMMUNOPHILIN FKBP12,ROTAMASE; COMPND 8 EC: 5.2.1.8; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A; COMPND 13 CHAIN: B, D; COMPND 14 SYNONYM: PPIASE FKBP1A,12 KDA FK506-BINDING PROTEIN,FKBP-12, COMPND 15 CALSTABIN-1,FK506-BINDING PROTEIN 1A,FKBP-1A,IMMUNOPHILIN FKBP12, COMPND 16 ROTAMASE; COMPND 17 EC: 5.2.1.8; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 83333, 9606; SOURCE 5 STRAIN: K-12; SOURCE 6 GENE: MALE, B4034, JW3994, FKBP1A, FKBP1, FKBP12; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: FKBP1A, FKBP1, FKBP12; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RAPAMYCIN, COMPLEX, KINASE, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.KIKUCHI,D.WU,T.INOUE,T.UMEHARA REVDAT 3 29-NOV-23 6M4V 1 REMARK REVDAT 2 16-SEP-20 6M4V 1 JRNL REVDAT 1 26-AUG-20 6M4V 0 JRNL AUTH H.D.WU,M.KIKUCHI,O.DAGLIYAN,A.K.ARAGAKI,H.NAKAMURA, JRNL AUTH 2 N.V.DOKHOLYAN,T.UMEHARA,T.INOUE JRNL TITL RATIONAL DESIGN AND IMPLEMENTATION OF A CHEMICALLY INDUCIBLE JRNL TITL 2 HETEROTRIMERIZATION SYSTEM. JRNL REF NAT.METHODS V. 17 928 2020 JRNL REFN ESSN 1548-7105 JRNL PMID 32747768 JRNL DOI 10.1038/S41592-020-0913-X REMARK 2 REMARK 2 RESOLUTION. 2.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 22328 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1295 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.92 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1671 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3080 REMARK 3 BIN FREE R VALUE SET COUNT : 82 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7181 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 136 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.61000 REMARK 3 B22 (A**2) : -3.27000 REMARK 3 B33 (A**2) : 1.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.46000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.513 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.483 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 52.166 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.886 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7511 ; 0.005 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 6924 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10218 ; 1.390 ; 1.670 REMARK 3 BOND ANGLES OTHERS (DEGREES): 16110 ; 1.159 ; 1.609 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 940 ; 6.073 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 337 ;32.452 ;24.421 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1174 ;14.937 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;14.037 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 994 ; 0.050 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8425 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1474 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3769 ; 1.854 ; 2.371 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3768 ; 1.854 ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4703 ; 2.740 ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 4704 ; 2.739 ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3742 ; 2.068 ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 3743 ; 2.068 ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 5515 ; 2.904 ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 8278 ; 4.264 ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 8278 ; 4.263 ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 7260 ; 1.994 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -367 A 32 REMARK 3 ORIGIN FOR THE GROUP (A): -53.6318 -1.8156 22.8168 REMARK 3 T TENSOR REMARK 3 T11: 0.2959 T22: 0.7234 REMARK 3 T33: 0.0970 T12: 0.0425 REMARK 3 T13: -0.1137 T23: 0.0628 REMARK 3 L TENSOR REMARK 3 L11: 0.9849 L22: 1.2613 REMARK 3 L33: 2.0878 L12: -0.3712 REMARK 3 L13: -1.1764 L23: 0.6724 REMARK 3 S TENSOR REMARK 3 S11: -0.0218 S12: 0.0398 S13: -0.1091 REMARK 3 S21: -0.0589 S22: -0.0405 S23: -0.1147 REMARK 3 S31: 0.1458 S32: 0.2053 S33: 0.0623 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 34 B 108 REMARK 3 ORIGIN FOR THE GROUP (A): -65.6397 6.2319 49.6303 REMARK 3 T TENSOR REMARK 3 T11: 0.2014 T22: 0.2501 REMARK 3 T33: 0.0334 T12: 0.0074 REMARK 3 T13: -0.0378 T23: 0.0396 REMARK 3 L TENSOR REMARK 3 L11: 4.4331 L22: 5.3920 REMARK 3 L33: 5.4717 L12: 0.8785 REMARK 3 L13: 1.0414 L23: 1.0282 REMARK 3 S TENSOR REMARK 3 S11: 0.1339 S12: -0.1040 S13: -0.3266 REMARK 3 S21: 0.2594 S22: -0.0966 S23: -0.1488 REMARK 3 S31: 0.0334 S32: -0.0743 S33: -0.0373 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C -367 C 32 REMARK 3 ORIGIN FOR THE GROUP (A): -30.6672 -3.0041 81.4031 REMARK 3 T TENSOR REMARK 3 T11: 0.3236 T22: 0.6283 REMARK 3 T33: 0.0465 T12: -0.0428 REMARK 3 T13: -0.1108 T23: -0.0400 REMARK 3 L TENSOR REMARK 3 L11: 1.0847 L22: 1.1223 REMARK 3 L33: 1.4900 L12: 0.2584 REMARK 3 L13: -0.6127 L23: -0.4958 REMARK 3 S TENSOR REMARK 3 S11: 0.0284 S12: -0.0484 S13: -0.0196 REMARK 3 S21: 0.0666 S22: -0.0169 S23: 0.0257 REMARK 3 S31: 0.0851 S32: 0.0393 S33: -0.0115 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 34 D 108 REMARK 3 ORIGIN FOR THE GROUP (A): -18.8647 4.6589 54.6361 REMARK 3 T TENSOR REMARK 3 T11: 0.2066 T22: 0.3521 REMARK 3 T33: 0.0188 T12: -0.0474 REMARK 3 T13: -0.0075 T23: -0.0679 REMARK 3 L TENSOR REMARK 3 L11: 5.5823 L22: 6.6463 REMARK 3 L33: 5.0687 L12: -0.6422 REMARK 3 L13: 1.8246 L23: -0.1648 REMARK 3 S TENSOR REMARK 3 S11: 0.2098 S12: 0.0936 S13: -0.0915 REMARK 3 S21: -0.2830 S22: -0.2068 S23: 0.2079 REMARK 3 S31: 0.0605 S32: 0.0517 S33: -0.0030 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 REMARK 3 SF FILE CONTAINS FRIEDEL PAIRS UNDER I/F_MINUS AND I/F_PLUS REMARK 3 COLUMNS. REMARK 4 REMARK 4 6M4V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1300016082. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23633 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.920 REMARK 200 RESOLUTION RANGE LOW (A) : 48.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1FAP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM NA-HEPES BUFFER (PH 7.5), 20% REMARK 280 (W/V) PEG 8000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.07200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -372 REMARK 465 SER A -371 REMARK 465 MET A -370 REMARK 465 LYS A -369 REMARK 465 ILE A -368 REMARK 465 SER A -297 REMARK 465 GLY A -296 REMARK 465 LEU A -295 REMARK 465 LEU A -294 REMARK 465 ASP B 33 REMARK 465 GLY C -372 REMARK 465 SER C -371 REMARK 465 MET C -370 REMARK 465 LYS C -369 REMARK 465 ILE C -368 REMARK 465 SER C -297 REMARK 465 GLY C -296 REMARK 465 LEU C -295 REMARK 465 LEU C -294 REMARK 465 ASP D 33 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A-367 CG CD OE1 OE2 REMARK 470 LYS A-364 CG CD CE NZ REMARK 470 LYS A-336 CG CD CE NZ REMARK 470 ASP A-329 CG OD1 OD2 REMARK 470 LYS A-328 CG CD CE NZ REMARK 470 GLN A-298 CG CD OE1 NE2 REMARK 470 ILE A-291 CG1 CG2 CD1 REMARK 470 PHE A-285 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A-282 CG CD CE NZ REMARK 470 LYS A-230 CG CD CE NZ REMARK 470 LYS A -8 CG CD CE NZ REMARK 470 LYS A 18 CG CD CE NZ REMARK 470 ARG A 19 CG CD NE CZ NH1 NH2 REMARK 470 GLU C-367 CG CD OE1 OE2 REMARK 470 LYS C-364 CG CD CE NZ REMARK 470 LYS C-336 CG CD CE NZ REMARK 470 GLN C-298 CG CD OE1 NE2 REMARK 470 ILE C-291 CG1 CG2 CD1 REMARK 470 PHE C-285 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS C-282 CG CD CE NZ REMARK 470 LYS C-230 CG CD CE NZ REMARK 470 LYS C 18 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A-328 56.04 -119.98 REMARK 500 ALA A-286 -72.72 -129.06 REMARK 500 ILE A-262 -62.47 -126.17 REMARK 500 GLU A-259 71.19 -109.52 REMARK 500 ALA A-202 -71.23 -60.11 REMARK 500 ASN A -98 31.26 -88.61 REMARK 500 TYR A -87 -52.11 -133.46 REMARK 500 LEU A -85 60.21 -69.88 REMARK 500 SER A -64 -71.74 -32.76 REMARK 500 ARG A 14 -62.41 -98.82 REMARK 500 ALA B 82 -121.26 -110.62 REMARK 500 GLU C-366 -168.53 -174.25 REMARK 500 LYS C-328 54.38 -110.04 REMARK 500 ALA C-286 -63.97 -103.60 REMARK 500 ILE C-262 -53.69 -120.75 REMARK 500 LEU C-248 90.52 -170.97 REMARK 500 ASN C-220 104.29 -56.04 REMARK 500 ASN C-129 102.60 -55.69 REMARK 500 LYS C-114 70.24 -109.52 REMARK 500 ASN C -98 32.55 -88.97 REMARK 500 SER D 78 150.86 -36.96 REMARK 500 ALA D 82 -123.91 -104.20 REMARK 500 ILE D 91 -58.61 -127.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 272 DISTANCE = 6.51 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue RAP B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue RAP D 201 DBREF 6M4V A -369 -4 UNP P0AEX9 MALE_ECOLI 27 392 DBREF 6M4V A 1 32 UNP P62942 FKB1A_HUMAN 1 32 DBREF 6M4V B 33 108 UNP P62942 FKB1A_HUMAN 33 108 DBREF 6M4V C -369 -4 UNP P0AEX9 MALE_ECOLI 27 392 DBREF 6M4V C 1 32 UNP P62942 FKB1A_HUMAN 1 32 DBREF 6M4V D 33 108 UNP P62942 FKB1A_HUMAN 33 108 SEQADV 6M4V GLY A -372 UNP P0AEX9 LINKER SEQADV 6M4V SER A -371 UNP P0AEX9 LINKER SEQADV 6M4V MET A -370 UNP P0AEX9 LINKER SEQADV 6M4V ALA A -288 UNP P0AEX9 ASP 108 ENGINEERED MUTATION SEQADV 6M4V ALA A -287 UNP P0AEX9 LYS 109 ENGINEERED MUTATION SEQADV 6M4V ALA A -198 UNP P0AEX9 GLU 198 ENGINEERED MUTATION SEQADV 6M4V ALA A -197 UNP P0AEX9 ASN 199 ENGINEERED MUTATION SEQADV 6M4V ALA A -131 UNP P0AEX9 LYS 265 ENGINEERED MUTATION SEQADV 6M4V ASN A -3 UNP P0AEX9 LINKER SEQADV 6M4V ALA A -2 UNP P0AEX9 LINKER SEQADV 6M4V ALA A -1 UNP P0AEX9 LINKER SEQADV 6M4V ALA A 0 UNP P0AEX9 LINKER SEQADV 6M4V GLY C -372 UNP P0AEX9 LINKER SEQADV 6M4V SER C -371 UNP P0AEX9 LINKER SEQADV 6M4V MET C -370 UNP P0AEX9 LINKER SEQADV 6M4V ALA C -288 UNP P0AEX9 ASP 108 ENGINEERED MUTATION SEQADV 6M4V ALA C -287 UNP P0AEX9 LYS 109 ENGINEERED MUTATION SEQADV 6M4V ALA C -198 UNP P0AEX9 GLU 198 ENGINEERED MUTATION SEQADV 6M4V ALA C -197 UNP P0AEX9 ASN 199 ENGINEERED MUTATION SEQADV 6M4V ALA C -131 UNP P0AEX9 LYS 265 ENGINEERED MUTATION SEQADV 6M4V ASN C -3 UNP P0AEX9 LINKER SEQADV 6M4V ALA C -2 UNP P0AEX9 LINKER SEQADV 6M4V ALA C -1 UNP P0AEX9 LINKER SEQADV 6M4V ALA C 0 UNP P0AEX9 LINKER SEQRES 1 A 405 GLY SER MET LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP SEQRES 2 A 405 ILE ASN GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL SEQRES 3 A 405 GLY LYS LYS PHE GLU LYS ASP THR GLY ILE LYS VAL THR SEQRES 4 A 405 VAL GLU HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN SEQRES 5 A 405 VAL ALA ALA THR GLY ASP GLY PRO ASP ILE ILE PHE TRP SEQRES 6 A 405 ALA HIS ASP ARG PHE GLY GLY TYR ALA GLN SER GLY LEU SEQRES 7 A 405 LEU ALA GLU ILE THR PRO ALA ALA ALA PHE GLN ASP LYS SEQRES 8 A 405 LEU TYR PRO PHE THR TRP ASP ALA VAL ARG TYR ASN GLY SEQRES 9 A 405 LYS LEU ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SER SEQRES 10 A 405 LEU ILE TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS SEQRES 11 A 405 THR TRP GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS SEQRES 12 A 405 ALA LYS GLY LYS SER ALA LEU MET PHE ASN LEU GLN GLU SEQRES 13 A 405 PRO TYR PHE THR TRP PRO LEU ILE ALA ALA ASP GLY GLY SEQRES 14 A 405 TYR ALA PHE LYS TYR ALA ALA GLY LYS TYR ASP ILE LYS SEQRES 15 A 405 ASP VAL GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU SEQRES 16 A 405 THR PHE LEU VAL ASP LEU ILE LYS ASN LYS HIS MET ASN SEQRES 17 A 405 ALA ASP THR ASP TYR SER ILE ALA GLU ALA ALA PHE ASN SEQRES 18 A 405 LYS GLY GLU THR ALA MET THR ILE ASN GLY PRO TRP ALA SEQRES 19 A 405 TRP SER ASN ILE ASP THR SER ALA VAL ASN TYR GLY VAL SEQRES 20 A 405 THR VAL LEU PRO THR PHE LYS GLY GLN PRO SER LYS PRO SEQRES 21 A 405 PHE VAL GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SER SEQRES 22 A 405 PRO ASN LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR SEQRES 23 A 405 LEU LEU THR ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP SEQRES 24 A 405 LYS PRO LEU GLY ALA VAL ALA LEU LYS SER TYR GLU GLU SEQRES 25 A 405 GLU LEU ALA LYS ASP PRO ARG ILE ALA ALA THR MET GLU SEQRES 26 A 405 ASN ALA GLN LYS GLY GLU ILE MET PRO ASN ILE PRO GLN SEQRES 27 A 405 MET SER ALA PHE TRP TYR ALA VAL ARG THR ALA VAL ILE SEQRES 28 A 405 ASN ALA ALA SER GLY ARG GLN THR VAL ASP GLU ALA LEU SEQRES 29 A 405 LYS ASP ALA GLN THR ASN ALA ALA ALA MET GLY VAL GLN SEQRES 30 A 405 VAL GLU THR ILE SER PRO GLY ASP GLY ARG THR PHE PRO SEQRES 31 A 405 LYS ARG GLY GLN THR CYS VAL VAL HIS TYR THR GLY MET SEQRES 32 A 405 LEU GLU SEQRES 1 B 76 ASP GLY LYS LYS PHE ASP SER SER ARG ASP ARG ASN LYS SEQRES 2 B 76 PRO PHE LYS PHE MET LEU GLY LYS GLN GLU VAL ILE ARG SEQRES 3 B 76 GLY TRP GLU GLU GLY VAL ALA GLN MET SER VAL GLY GLN SEQRES 4 B 76 ARG ALA LYS LEU THR ILE SER PRO ASP TYR ALA TYR GLY SEQRES 5 B 76 ALA THR GLY HIS PRO GLY ILE ILE PRO PRO HIS ALA THR SEQRES 6 B 76 LEU VAL PHE ASP VAL GLU LEU LEU LYS LEU GLU SEQRES 1 C 405 GLY SER MET LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP SEQRES 2 C 405 ILE ASN GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL SEQRES 3 C 405 GLY LYS LYS PHE GLU LYS ASP THR GLY ILE LYS VAL THR SEQRES 4 C 405 VAL GLU HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN SEQRES 5 C 405 VAL ALA ALA THR GLY ASP GLY PRO ASP ILE ILE PHE TRP SEQRES 6 C 405 ALA HIS ASP ARG PHE GLY GLY TYR ALA GLN SER GLY LEU SEQRES 7 C 405 LEU ALA GLU ILE THR PRO ALA ALA ALA PHE GLN ASP LYS SEQRES 8 C 405 LEU TYR PRO PHE THR TRP ASP ALA VAL ARG TYR ASN GLY SEQRES 9 C 405 LYS LEU ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SER SEQRES 10 C 405 LEU ILE TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS SEQRES 11 C 405 THR TRP GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS SEQRES 12 C 405 ALA LYS GLY LYS SER ALA LEU MET PHE ASN LEU GLN GLU SEQRES 13 C 405 PRO TYR PHE THR TRP PRO LEU ILE ALA ALA ASP GLY GLY SEQRES 14 C 405 TYR ALA PHE LYS TYR ALA ALA GLY LYS TYR ASP ILE LYS SEQRES 15 C 405 ASP VAL GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU SEQRES 16 C 405 THR PHE LEU VAL ASP LEU ILE LYS ASN LYS HIS MET ASN SEQRES 17 C 405 ALA ASP THR ASP TYR SER ILE ALA GLU ALA ALA PHE ASN SEQRES 18 C 405 LYS GLY GLU THR ALA MET THR ILE ASN GLY PRO TRP ALA SEQRES 19 C 405 TRP SER ASN ILE ASP THR SER ALA VAL ASN TYR GLY VAL SEQRES 20 C 405 THR VAL LEU PRO THR PHE LYS GLY GLN PRO SER LYS PRO SEQRES 21 C 405 PHE VAL GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SER SEQRES 22 C 405 PRO ASN LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR SEQRES 23 C 405 LEU LEU THR ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP SEQRES 24 C 405 LYS PRO LEU GLY ALA VAL ALA LEU LYS SER TYR GLU GLU SEQRES 25 C 405 GLU LEU ALA LYS ASP PRO ARG ILE ALA ALA THR MET GLU SEQRES 26 C 405 ASN ALA GLN LYS GLY GLU ILE MET PRO ASN ILE PRO GLN SEQRES 27 C 405 MET SER ALA PHE TRP TYR ALA VAL ARG THR ALA VAL ILE SEQRES 28 C 405 ASN ALA ALA SER GLY ARG GLN THR VAL ASP GLU ALA LEU SEQRES 29 C 405 LYS ASP ALA GLN THR ASN ALA ALA ALA MET GLY VAL GLN SEQRES 30 C 405 VAL GLU THR ILE SER PRO GLY ASP GLY ARG THR PHE PRO SEQRES 31 C 405 LYS ARG GLY GLN THR CYS VAL VAL HIS TYR THR GLY MET SEQRES 32 C 405 LEU GLU SEQRES 1 D 76 ASP GLY LYS LYS PHE ASP SER SER ARG ASP ARG ASN LYS SEQRES 2 D 76 PRO PHE LYS PHE MET LEU GLY LYS GLN GLU VAL ILE ARG SEQRES 3 D 76 GLY TRP GLU GLU GLY VAL ALA GLN MET SER VAL GLY GLN SEQRES 4 D 76 ARG ALA LYS LEU THR ILE SER PRO ASP TYR ALA TYR GLY SEQRES 5 D 76 ALA THR GLY HIS PRO GLY ILE ILE PRO PRO HIS ALA THR SEQRES 6 D 76 LEU VAL PHE ASP VAL GLU LEU LEU LYS LEU GLU HET RAP B 201 65 HET GOL C 101 6 HET RAP D 201 65 HETNAM RAP RAPAMYCIN IMMUNOSUPPRESSANT DRUG HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 RAP 2(C51 H79 N O13) FORMUL 6 GOL C3 H8 O3 FORMUL 8 HOH *154(H2 O) HELIX 1 AA1 GLY A -357 LYS A -355 5 3 HELIX 2 AA2 GLY A -354 GLY A -338 1 17 HELIX 3 AA3 LYS A -328 ALA A -318 1 11 HELIX 4 AA4 HIS A -306 GLN A -298 1 9 HELIX 5 AA5 TYR A -280 VAL A -273 1 8 HELIX 6 AA6 GLU A -240 GLY A -227 1 14 HELIX 7 AA7 THR A -213 ALA A -208 1 6 HELIX 8 AA8 ALA A -207 GLY A -205 5 3 HELIX 9 AA9 ASN A -185 ASN A -169 1 17 HELIX 10 AB1 ASP A -161 GLY A -150 1 12 HELIX 11 AB2 ALA A -139 SER A -132 1 8 HELIX 12 AB3 ASN A -98 TYR A -87 1 12 HELIX 13 AB4 THR A -84 LYS A -73 1 12 HELIX 14 AB5 LEU A -66 ALA A -58 1 9 HELIX 15 AB6 ASP A -56 GLY A -43 1 14 HELIX 16 AB7 GLN A -35 SER A -18 1 18 HELIX 17 AB8 THR A -14 ALA A 0 1 15 HELIX 18 AB9 SER B 40 ASN B 44 1 5 HELIX 19 AC1 ILE B 57 ALA B 65 1 9 HELIX 20 AC2 PRO B 79 ALA B 82 5 4 HELIX 21 AC3 GLY C -354 GLY C -338 1 17 HELIX 22 AC4 LYS C -328 THR C -317 1 12 HELIX 23 AC5 HIS C -306 GLN C -298 1 9 HELIX 24 AC6 TYR C -280 VAL C -273 1 8 HELIX 25 AC7 GLU C -240 ALA C -229 1 12 HELIX 26 AC8 GLU C -217 ALA C -208 1 10 HELIX 27 AC9 ASN C -185 ASN C -169 1 17 HELIX 28 AD1 ASP C -161 LYS C -151 1 11 HELIX 29 AD2 GLY C -142 TRP C -140 5 3 HELIX 30 AD3 ALA C -139 SER C -132 1 8 HELIX 31 AD4 ASN C -98 TYR C -87 1 12 HELIX 32 AD5 THR C -84 LYS C -73 1 12 HELIX 33 AD6 LEU C -66 ALA C -58 1 9 HELIX 34 AD7 ASP C -56 GLY C -43 1 14 HELIX 35 AD8 GLN C -35 GLY C -17 1 19 HELIX 36 AD9 THR C -14 ALA C 0 1 15 HELIX 37 AE1 SER D 40 ASN D 44 1 5 HELIX 38 AE2 ILE D 57 ALA D 65 1 9 SHEET 1 AA1 6 VAL A-335 GLU A-332 0 SHEET 2 AA1 6 LEU A-363 ILE A-359 1 N ILE A-361 O GLU A-332 SHEET 3 AA1 6 ILE A-311 ALA A-307 1 O PHE A-309 N TRP A-360 SHEET 4 AA1 6 PHE A-112 ILE A-104 -1 O SER A-107 N TRP A-308 SHEET 5 AA1 6 ALA A-265 GLU A-259 -1 N GLU A-259 O GLY A-110 SHEET 6 AA1 6 ALA A -69 VAL A -68 -1 O ALA A -69 N VAL A-260 SHEET 1 AA2 5 VAL A-335 GLU A-332 0 SHEET 2 AA2 5 LEU A-363 ILE A-359 1 N ILE A-361 O GLU A-332 SHEET 3 AA2 5 ILE A-311 ALA A-307 1 O PHE A-309 N TRP A-360 SHEET 4 AA2 5 PHE A-112 ILE A-104 -1 O SER A-107 N TRP A-308 SHEET 5 AA2 5 GLU A -42 ILE A -41 1 O GLU A -42 N VAL A-111 SHEET 1 AA3 2 ARG A-272 TYR A-271 0 SHEET 2 AA3 2 LYS A-268 LEU A-267 -1 O LYS A-268 N TYR A-271 SHEET 1 AA4 3 MET A-146 ASN A-143 0 SHEET 2 AA4 3 SER A-256 ASN A-252 -1 N ILE A-254 O THR A-145 SHEET 3 AA4 3 TYR A-128 THR A-125 -1 O THR A-125 N LEU A-255 SHEET 1 AA5 2 TYR A-203 ALA A-198 0 SHEET 2 AA5 2 LYS A-195 GLY A-188 -1 O ASP A-193 N LYS A-200 SHEET 1 AA6 5 VAL A 3 SER A 9 0 SHEET 2 AA6 5 ARG B 72 ILE B 77 -1 O ARG B 72 N ILE A 8 SHEET 3 AA6 5 LEU B 98 GLU B 108 -1 O PHE B 100 N LEU B 75 SHEET 4 AA6 5 THR A 22 LEU A 31 -1 N VAL A 24 O LYS B 106 SHEET 5 AA6 5 LYS B 36 SER B 39 -1 O ASP B 38 N GLY A 29 SHEET 1 AA7 5 VAL A 3 SER A 9 0 SHEET 2 AA7 5 ARG B 72 ILE B 77 -1 O ARG B 72 N ILE A 8 SHEET 3 AA7 5 LEU B 98 GLU B 108 -1 O PHE B 100 N LEU B 75 SHEET 4 AA7 5 THR A 22 LEU A 31 -1 N VAL A 24 O LYS B 106 SHEET 5 AA7 5 PHE B 47 MET B 50 -1 O PHE B 49 N CYS A 23 SHEET 1 AA8 6 VAL C-335 GLU C-332 0 SHEET 2 AA8 6 LEU C-363 TRP C-360 1 N ILE C-361 O THR C-334 SHEET 3 AA8 6 ILE C-311 ALA C-307 1 O ILE C-311 N TRP C-360 SHEET 4 AA8 6 PHE C-112 ILE C-104 -1 O SER C-107 N TRP C-308 SHEET 5 AA8 6 ALA C-265 GLU C-259 -1 N ILE C-262 O LEU C-108 SHEET 6 AA8 6 ALA C -69 VAL C -68 -1 O ALA C -69 N VAL C-260 SHEET 1 AA9 5 VAL C-335 GLU C-332 0 SHEET 2 AA9 5 LEU C-363 TRP C-360 1 N ILE C-361 O THR C-334 SHEET 3 AA9 5 ILE C-311 ALA C-307 1 O ILE C-311 N TRP C-360 SHEET 4 AA9 5 PHE C-112 ILE C-104 -1 O SER C-107 N TRP C-308 SHEET 5 AA9 5 GLU C -42 ILE C -41 1 O GLU C -42 N VAL C-111 SHEET 1 AB1 2 ARG C-272 TYR C-271 0 SHEET 2 AB1 2 LYS C-268 LEU C-267 -1 O LYS C-268 N TYR C-271 SHEET 1 AB2 4 SER C-225 LEU C-223 0 SHEET 2 AB2 4 THR C-148 ASN C-143 1 O MET C-146 N ALA C-224 SHEET 3 AB2 4 SER C-256 ASN C-252 -1 N ASN C-252 O ALA C-147 SHEET 4 AB2 4 TYR C-128 THR C-125 -1 O GLY C-127 N TYR C-253 SHEET 1 AB3 2 TYR C-203 TYR C-199 0 SHEET 2 AB3 2 TYR C-194 GLY C-188 -1 O ASP C-193 N LYS C-200 SHEET 1 AB4 5 VAL C 3 SER C 9 0 SHEET 2 AB4 5 ARG D 72 ILE D 77 -1 O LYS D 74 N GLU C 6 SHEET 3 AB4 5 LEU D 98 GLU D 108 -1 O LEU D 98 N ILE D 77 SHEET 4 AB4 5 THR C 22 LEU C 31 -1 N HIS C 26 O GLU D 103 SHEET 5 AB4 5 LYS D 35 SER D 39 -1 O ASP D 38 N GLY C 29 SHEET 1 AB5 5 VAL C 3 SER C 9 0 SHEET 2 AB5 5 ARG D 72 ILE D 77 -1 O LYS D 74 N GLU C 6 SHEET 3 AB5 5 LEU D 98 GLU D 108 -1 O LEU D 98 N ILE D 77 SHEET 4 AB5 5 THR C 22 LEU C 31 -1 N HIS C 26 O GLU D 103 SHEET 5 AB5 5 PHE D 47 MET D 50 -1 O PHE D 47 N VAL C 25 SITE 1 AC1 12 TYR A 27 PHE B 37 ASP B 38 PHE B 47 SITE 2 AC1 12 GLN B 54 GLU B 55 VAL B 56 ILE B 57 SITE 3 AC1 12 TRP B 60 TYR B 83 ILE B 92 PHE B 100 SITE 1 AC2 14 TYR C 27 PHE D 37 ASP D 38 PHE D 47 SITE 2 AC2 14 GLN D 54 GLU D 55 VAL D 56 ILE D 57 SITE 3 AC2 14 TRP D 60 TYR D 83 ILE D 91 ILE D 92 SITE 4 AC2 14 PHE D 100 HOH D 303 CRYST1 107.026 48.144 108.730 90.00 106.52 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009344 0.000000 0.002772 0.00000 SCALE2 0.000000 0.020771 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009593 0.00000